MidAtlantic Capital Management’s Johnson & Johnson JNJ Stock Holding History

MidAtlantic Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-181	Closed	-$37.5K	–	149
2025 Q4	$37.5K	Buy	+181	New	+$35.8K	0.02%	162
2025 Q1	–	Sell	-181	Closed	-$26.2K	–	150
2024 Q4	$26.2K	Sell	181 -165	-48%	-$25.6K	0.02%	165
2024 Q3	$56.1K	Hold	346	–	–	0.04%	124
2024 Q2	$50.6K	Hold	346	–	–	0.04%	126
2024 Q1	$54.7K	Hold	346	–	–	0.05%	126
2023 Q4	$54.2K	Buy	+346	New	+$53.1K	0.05%	122

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MidAtlantic Capital Management's JNJ Position: Q1 2026 in Review

MidAtlantic Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 181 shares — an estimated $37.5K sold.

MidAtlantic Capital Management first reported a position in JNJ in Q4 2023 and held it in 6 quarters. The position peaked at $56.1K in Q3 2024. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

MidAtlantic Capital Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
MidAtlantic Capital Management sold 181 Johnson & Johnson shares in Q1 2026, an estimated $37.5K.
MidAtlantic Capital Management first reported a position in Johnson & Johnson in Q4 2023 and held it in 6 quarters.
MidAtlantic Capital Management's Johnson & Johnson position peaked at $56.1K in Q3 2024.
4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on MidAtlantic Capital Management's 13F filing for Q1 2026, filed 8 May 2026.